Fort Worth's Group Health Insurance Benefits Leads Spring ACA Enrollment For 2021

Fort Worth Small Group Health Insurance

Fort Worth Small Group Health Insurance

Fort Worth Small Business Group Health Insurance

Fort Worth Small Business Group Health Insurance

Group Health Insurance Fort Worth

Group Health Insurance Fort Worth

Health insurance agent group health insurance in Fort Worth

Health insurance agent group health insurance in Fort Worth

Fort Worth Group Health Insurance

Fort Worth Group Health Insurance

A Fort Worth's group health insurance agent says the Biden’s decision to reopen enrollment for the ACA is a good sign for those who desperately need healthcare.

FORT WORTH, TEXAS, US, March 7, 2021 / — Fort Worth small group health insurance should see a spike in enrollment now that the President has reopened enrollment for the Affordable Care Act on the Federal Marketplace through May 15 of 2021. The decision is being applauded by practically everyone while at the same time being viewed as a clear message that the ACA isn’t going anywhere anytime soon.

The timeline for the enrollment does vary per state — including Texas, which has Fort Worth small business group health insurance. But many politicians and pundits are applauding the move as an encouraging sign of good things to come for a nation that has seen its fair share of strife over the past year. The Coronavirus, in-particular, has claimed more than 520,000 American lives and left others searching for affordable healthcare.

According to the Kaiser Family Foundation, roughly nine million uninsured Americans are estimated to obtain free or subsidized health insurance during the special enrollment period. “Now we have a chance to provide health insurance for more people. We applaud the Biden-Harris administration for taking decisive action to make health insurance coverage more accessible by reopening enrollment for three months. Doing so surely will save lives and help protect people against financial insecurity,” Marcela Howell, president and CEO of In Our Own Voice: National Black Women’s Reproductive Justice Agenda, was quoted as saying in The Seattle Medium.

Rick Thornton, a health insurance agent who sells group health insurance in Fort Worth, agrees with the move, as well. The ACA was originally signed into law in 2010 but has been under fire since Donald Trump came to office and his allies worked to repeal the bill in its entirety. The number of Americans without small group health insurance in Fort Worth began had risen since he took office in 2016 and has gotten worse. With enrollment now open and a more positive light being placed on the ACA, Thornton feels that this will benefit the insured, uninsured, and nationwide insurers everywhere.

Insurance4Dallas, (I4D), helps insure all of Texas, Oklahoma, Arkansas, Arizona, Louisiana, New Mexico, Alabama, Virginia and Florida. Insurance4Dallas provides consumers with detailed information on health insurance with the ability to purchase health insurance online. Insurance4Dallas provides a full spectrum of health, dental, vision, life and ancillary insurance products, providing a diverse selection of price and benefit options complemented by personal customer service. Available via phone, email or fax, Insurance4Dallas answers consumer questions throughout the purchasing process and during the utilization of its health insurance policies.

3000 S. Hulen, Suite 124-912
Fort Worth, TX 76109

Rick Thornton
+1 817-710-3783
email us here

Fort Worth health insurance covered if Affordable Care Act is repealed

Source: EIN Presswire

Air Quality Sensor Modules for 6 Gases and VOCs

7 Series Air Quality Sensors with sensitivity in the ppb range

Air Quality Sensors with sensitivity in the ppb range

Now there are Electrochemical Sensors for monitoring low levels of CO, NO2, O3, SO2, NO or H2S gases. There are also reliable PID sensors for measuring VOCs.

The ppb sensitivity of these sensors makes them the best available.”

— Fei Shen

SANTA ROSA, CA, UNITED STATES, March 6, 2021 / — There now are Electrochemical Sensors for monitoring low levels of CO, NO2, O3, SO2, NO or H2S gases (key contributors to poor air quality). There are also reliable PID sensors for measuring VOCs. The gas sensors are designed for air quality monitoring to measure the low-concentration CO, NO2, O3, SO2, NO or H2S gas with ultra-high resolutions. The design optimizes the sensor sensitivity, accuracy and long-term stability and enables the sensor to detect variations at parts per billion (ppb) levels.

The PID Sensors are designed for the detection of a wide variety of volatile organic compounds (VOCs). In general, any compound with ionization energy (IE) lower than that of the lamp photons can be measured. Based on its proprietary ultraviolet (UV) lamp technology, Senovol PID sensors have the advanced features of high UV outputs, and long lamp life spans.

Bill Bolster
Electro Optical Components, Inc.
+ +1 707-568-1642
email us here

Source: EIN Presswire

Metro Infusion Center continues to expand its infusion therapy services

Now open, Metro Infusion Center located at 30 La Casa Via, Building 2, Suite 108, Walnut Creek, CA, 94598.

The staff and medical team go out of their way to make sure patients are comfortable, understand their options, and have an agreed-upon plan of action for their treatments.”

— Michael D.

BURR RIDGE, IL, UNITED STATES, March 6, 2021 / — Metro Infusion Center, a top provider of infusion treatments, is thrilled to announce the addition of a new office located at 130 La Casa Via, Building 2, Suite 108, Walnut Creek, CA, 94598. The Walnut Creek, CA, office joins several other West Coast facilities in California, Nevada, and Arizona.

With more than two decades of experience, Metro Infusion Center specializes in infusion therapy treatments for chronic conditions such as Crohn’s disease, rheumatoid arthritis, neurologic diseases, immune deficiencies, and other autoimmune conditions.

“Metro Infusion Center goes above and beyond,” patient Michael D. said. “The staff and medical team go out of their way to make sure patients are comfortable, understand their options, and have an agreed-upon plan of action for their treatments.”

Patient Support Services at the new Walnut Creek facility will continue to uphold Metro Infusion Center’s commitment to patient care, comfort, and confidence. The Patient Support team is fully equipped to manage insurance coverage questions and help patients navigate their treatment experience.

In addition to a top-notch medical and Patient Support team, Metro Infusion Center is known across the country for its kind and compassionate approach to treatment.

Neil Stanton
Metro Infusion Center
+1 630-654-4201
email us here
Visit us on social media:

Source: EIN Presswire

Medicare Advantage Plan Pros and Cons

Medicare Advantage

Medicare has many parts like a puzzle

Part D included

Part D costs

Medicare Made Simple

Paul Barrett Insurance Services

Is Medicare Advantage right for you?

Medicare coverage is very personal and not every plan is for everybody, it is important understand your options and needs.”

— Paul Barrett

HUNTINGTON STATION, NEW YORK, UNITED STATES, March 6, 2021 / — When it comes to Medicare Advantage Part C Plans or Medicare Advantage Plans, you may not always get what you want. Most people who have this plan are still unsure of what they'll get or their coverages. If you have a Medicare Advantage Plan and you're planning to take advantage of its benefits, make sure to understand its pros and cons first.

Pro: Plan Benefits Change Every Year According To Your Needs
As your needs change every year, your medical coverage should also. This is why you can change your plan anytime during the Initial Enrollment Period. This period starts three months before you turn 65 if you qualify for this plan by age.

Cons: The Free Plans Are Not Free
Some Medicare Advantage Part C plans have zero premiums, but this does not mean that it's free. Medicare Part C has low premiums compared to Medigap. Medicare pays a specific monthly payment to the insurance company to provide care.

Pro: Private Medicare Plans Are Pay-As-You-Go
MA Plans are provided by companies that are partnered with Medicare. You will only pay for extra coverage if you need it. This includes vision, dental, hearing, and other types of health and wellness extras.

Cons: You Can’t Count On These Plans When You Travel
Some types of Medical Advantage Plans can be accessed when you travel out of state. However, if you plan to take a trip out of the country, you can't take advantage of your coverage. You may instead use travel medical insurance plans to cover you when you're on a vacation or trip outside the U.S.

Pro: The Plans Limit Annual Out-Of-Pocket Cost
In 2021, Medicare Part C plan holders will have a $7,550 maximum out-of-pocket limit for services that Part A and Part B covers. This is if you select an in-network provider. Meanwhile, the limit is $11,300 annually for combination in and out-network costs.

Cons: You May Get a Referral
Most of the time, you need a referral to consult with a specialist under an HMO plan. Meanwhile, you don't need a referral to consult with a specialist in a PPO or Preferred Provider Organization plan. Therefore, you must make sure that you're seeing a doctor who participates in the Medicare plan program before scheduling an appointment.

Medicare Advantage C Plans offer many advantages than the Original Medicare, such as long-term savings and convenient coverage. Consider the advantages like provider limitations, lack of travel coverage, and additional costs before you sign up.

At Paul Barrett Insurance Services, we aim to provide comprehensive insurance policies that make your life easier. We want to help you get the insurance that fits your needs. You can get more information about our products and services by calling our agency at (631) 358-5793 . Get your free quote today by CLICKING HERE.

Paul Barrett
Paul Barrett Insurance Services
+1 631-358-5793
email us here
Visit us on social media:

Source: EIN Presswire

Metro Infusion Center continues to expand its operations nationwide

Metro Infusion Center offers infusion therapy in a comfortable, convenient outpatient setting.

"The nurses are very personable and can always answer all my questions about my infusion treatment.”

— Tammy Burke

BURR RIDGE, IL, UNITED STATES, March 6, 2021 / — Metro Infusion Center—a leading national provider of infusion therapies—has opened a new office in Ashburn, Virginia, located at 20925 Professional Plaza, Suite 310. This new location joins more than 100 Metro Infusion Center offices located nationwide. Metro Infusion Center offers infusion therapy in a comfortable, convenient outpatient setting and gives patients a new treatment option outside of a hospital environment.

Metro Infusion Center administers a variety of infusion and injection therapies for patients with chronic conditions, including multiple sclerosis, rheumatoid arthritis, Crohn's disease, and many others. Its staff works closely with physicians to develop individualized treatment plans for each of its patients based on their unique health situations and is devoted to creating a warm, welcoming treatment setting.

Metro Infusion Center has been delivering quality infusion therapy for more than two decades. Its practitioners maintain an expert knowledge of all infusions administered and thoroughly understand every stage of the treatment process, including dosing, administration, and follow-up care.

Patients of Metro Infusion Center generally receive infusion treatment for many years as part of chronic disease management. Patients have praised Metro Infusion Center for helping them identify and apply pharmaceutical rebates that make their treatments more affordable, and for having kind, compassionate staff members who make them feel right at home.

Metro Infusion Center continues to expand its operations nationwide and is dedicated to providing patients additional options when it comes to infusion therapies.

Neil Stanton
Metro Infusion Center
+1 630-654-4201
email us here

Source: EIN Presswire

Cancer Victims Ask Judge to Reject Bayer AG Roundup Weed Killer Cancer Lawsuit Settlement

Outcry grows over deal that would allow Bayer AG to continue selling cancer-causing herbicide while shielding it from future cancer claims


It is fundamentally unfair, and at odds with basic due-process protections, to force someone to opt out now when she has no idea what her circumstances might be if she becomes injured”

— Fears Nachawati Law Firm

SAN FRANCISCO, CA, UNITED STATES, March 5, 2021 / — A new court challenge is asking the federal judge overseeing thousands of Roundup weed killer cancer lawsuits to reject a proposed settlement that would allow Roundup maker Bayer AG (OTCMKTS: BAYRY) to continue selling the glyphosate-based herbicide while shielding it from future cancer lawsuits.

The motion filed Thursday by trial lawyers at Dallas-based Fears Nachawati Law Firm raises numerous questions about the proposal and highlights growing criticism of plaintiffs’ lawyers who have already negotiated with Bayer AG to obtain favorable settlements for their existing clients that would not be available to individuals not yet diagnosed. The motion describes the deal as “a one-way street that provides no benefits and imposes many burdens.”

Under the proposed settlement, individuals who were exposed to Roundup but had not filed a cancer claim by Feb. 3, 2021 would not be allowed to participate in class-action litigation and seek punitive damages in litigation and instead could only obtain compensation based on a multitiered formula. The challenge is filed on behalf of four plaintiffs – including three diagnosed with non-Hodgkin’s lymphoma – who have been exposed to Roundup and had not filed a lawsuit by Feb. 3. Bayer acquired the ownership rights to Roundup when it purchased Monsanto in 2018.

“It is fundamentally unfair, and at odds with basic due-process protections, to force someone to opt out now when she has no idea what her circumstances might be if she becomes injured,” the motion states.

“This proposed settlement is opposed by those most familiar with the litigation of cases involving dangerous products like Roundup because they recognize that this proposal would benefit Monsanto and class counsel at the expense of millions of people exposed to Roundup,” the motion states. “This is not a real lawsuit, but an effort to create an alternative dispute resolution mechanism in the guise of a class-action settlement.”

“There is no good reason why the class is limited to those who have already been exposed when Monsanto has no intention of stopping the sale of Roundup, or changing its composition, so that thousands of individuals will continue to run the risk of contracting [non-Hodgkin’s lymphoma] from Roundup through post-February 3, 2021 exposure. If this were a real lawsuit, why would any class representative (or class counsel) create a wholly artificial cut-off date and not include everyone who will be exposed to Roundup in the future?”

The multidistrict litigation (MDL) is In re Roundup Products Liability Litigation, case number 3:16-md-02741, in the U.S. District Court for the Northern District of California.

Dallas-based Fears Nachawati Law Firm represents more than 4,000 individual plaintiffs in active litigation against Bayer and continues to investigate new claims on behalf of those sickened after exposure to Roundup. For the past three years, the law firm was ranked number one nationally in product liability filings in federal court. For more information, visit 

John Raggio
Fears Nachawati
email us here
Visit us on social media:

Source: EIN Presswire

Pharmacists Group Urges Widespread Use, Equitable Allocation of FDA-Authorized COVID-19 Vaccines

ASHP looks to counter misperceptions about authorized vaccines that may compromise public acceptance.

BETHESDA, MARYLAND, UNITED STATES, March 5, 2021 / — Today, the American Society of Health-System Pharmacists (ASHP) issued the following statement on the use and allocation of vaccines authorized by the Food and Drug Administration (FDA) against the COVID-19.

This week represents an important milestone in combatting the COVID-19 global pandemic that has devastated families and communities for over a year. Thanks to the tireless efforts and innovation of scientists from around the world, there are now three viable vaccines against SARS-CoV-2 in the U.S.

“ASHP’s position is that all three FDA-authorized vaccines have – based on the available evidence – proven efficacious in preventing serious illness, hospitalization, and death from COVID-19," said Daniel J. Cobaugh, Pharm.D., DABAT, FAACT, vice president of publishing and editor-in-chief of the American Journal of Health-System Pharmacy (AJHP). “Individuals should obtain whichever vaccine is immediately available to them to protect themselves and others from COVID-19, support the establishment of herd immunity, and effectively respond to the pandemic.”

As a leader in the evidence-based evaluation of medications and vaccines, ASHP has evaluated the evidence and possesses great confidence that any authorized vaccine thus far promises population protection against clinically meaningful endpoints for COVID-19. After this careful evaluation, ASHP offers the following statements to counter any misperceptions about the vaccines that may compromise public acceptance.

ASHP urges widespread use and acceptance of all vaccines currently authorized by FDA. Time is of the essence. The landscape of COVID-19 is rapidly evolving due to the emergence of variants, and the global community has been experiencing the consequences of this pandemic for far too long. It is imperative to capitalize on the promise these vaccines offer as soon as possible. While there are slight differences with each vaccine, including clinical outcomes, adverse effects, and storage and handling considerations, they are all significantly effective in reducing severe symptoms, decreasing hospitalizations, and decreasing death from COVID-19. These endpoints hold promise to lessen the burden of disease and death in our communities and ease the strain on our healthcare system. Healthcare professionals need to message confidence in all of the vaccines and counter myths that may lead to hesitancy or misinformation.

ASHP calls for the equitable allocation of any vaccine across populations and communities, prioritized for the greatest public health impact, regardless of geographic or economic status. The COVID-19 pandemic has resulted in continued devastation of public health, economies, and geopolitical relations. ASHP is deeply concerned by the perception vaccines might be allocated based on population or socioeconomic status. Each COVID-19 vaccine clinical trial took place in different parts of the U.S. and the world, at different times and with varying rates of COVID-19 disease. However, each vaccine demonstrated a benefit to all populations evaluated for the emergency use authorization by FDA; therefore, any vaccine administered is an effective countermeasure to COVID-19. While logistical demands for the storage and handling of each vaccine may warrant allocation to a particular point of dispensing, there is no acceptable reason to allocate a vaccine solely based on population differences or socioeconomic status.

ASHP is the leader in trusted, authoritative sources of evidence-based drug information. The society develops professional and patient-focused scientific content that drives optimal medication use and health outcomes. ASHP stands ready to evaluate and educate on COVID-19 vaccine safety and efficacy data with a focus on thoroughly assessing advantages and disadvantages in different patient populations, including interpretation of the various claims of vaccine efficacy.

About ASHP
ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s nearly 58,000 members include pharmacists, student pharmacists, and pharmacy technicians. For 79 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP’s website,, or its consumer website,

Aretha Hankinson
ASHP (American Society of Health-System Pharmacists)
email us here
Visit us on social media:

Source: EIN Presswire

Emergence Global Enterprises Inc. Announces Acquisition of ProDynn Distribution LLC

WINDSOR, ONTARIO, CANADA, March 5, 2021 / — Emergence Global Enterprises Inc. (“Emergence Global” or the “Company”) (CSE: EMRG) (OTCQB: ELOAF), an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands, is pleased to announce that it has completed its acquisition of all of the issued and outstanding member shares in the capital of ProDynn Distribution, LLC ("ProDynn") (the "Transaction"), a distributor of branded all-natural foods, sports, and nutrition specialty supplements. The acquisition was completed pursuant to a share purchase agreement (the “Purchase Agreement”), dated March 5, 2021. Under the terms of the Purchase Agreement, the sole member of ProDynn (the "Vendor") received aggregate consideration of 1,000,000 common shares in the capital of the Company ("Common Shares") issued to the Vendor at the closing time. The Price per Share at the close of the market on the day prior was $.85.

According to Joe Byrne, President & CEO of Emergence Global Enterprises, “The acquisition of ProDynn Distribution will provide the needed logistics and supply chain support that is needed by Emergence Global enterprises as we continue to expand our footprint across the food and nutrition marketplace.” Jeff Hoffman of ProDynn Distribution, LLC said that” This move to join a growing company in the health and nutrition marketplace provides ProDynn with additional products, channels, and potential customers as both companies continue to expand their scope of operations. We look forward to joining Emergence and bringing our great value, service, and dedication to our industry and customers.”

Additional information about the Company can be found on SEDAR under the Issuer Profile of “Emergence Global Enterprises Inc." or on OTC MARKETS.

About the Company
Emergence Global Enterprises Inc. ("Emergence") is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Following the acquisition of Nubreed Nutrition, Inc., Emergence has become a North American developer and distributor of branded sports and nutrition specialty supplements. The Company is currently considering several development projects.

For further information on the Company, please contact: Joseph Byrne, President & Chief Executive Officer and a Director at phone: 519-257-0460 or by email at:

Cautionary Statement Regarding Forward-Looking Information

Forward-Looking Statements
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward- looking statements, whether as a result of new information, future events or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic or strategic benefits will be realized.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) or OTC Markets accepts responsibility for the adequacy or accuracy of this press release.

Joseph Byrne
Emergence Global Enterprises Inc.
+1 519 257 0460
email us here

Source: EIN Presswire

UniCox SuperFoods Organic Products Launches KickStarter Campaign

Power Breakfast Blend with SuperFoods Introduced for People with Dietary Restrictions

TORONTO, CANADA, March 5, 2021 / — Today, UniCox SuperFoods announced the launch of its KickStarter campaign to raise funds for its ambitious, clean, organic foods company. This specialized purveyor of products is establishing a new brand for people with specific food preferences and dietary concerns. Its flagship Power Breakfast Blend is made with all natural, organic ingredients and no sugar or gluten. UniCox Super Foods will develop and continue to offer new, clean and outstanding vegan products.

“Unicox started in 2020 after its founder could not find a breakfast drink or shake on the market that met her dietary needs,” said a spokesperson for UniCox Super Foods. “Clean ingredients are important to so many consumers. The problem is that most breakfasts are very high in various sugars and they contain gluten, fillers, artificial flavors and coloring. Our company offers better choices.”

UniCox is more than a business venture for the company’s founder. It represents a solution to a personal health challenge she faced. In 2019, the founder was diagnosed with polycystic ovary syndrome (PCOS). A few of the symptoms she was experiencing were weight gain and fatigue. She made a decision and decided to change her eating lifestyle and completely re-evaluated her food intake. Within weeks of trading bread and pasta for nuts and avocados, she achieved a remarkable rebound in the way she felt and performed. To keep her PCOS normal, she went gluten free and adopted the keto diet.

The founder is far from alone. Millions of people have comparable health and diet needs. These insights led to the formation of UniCox, which is addressing this emerging market need. The founder, who describes herself as a “one-women army,” is raising funds on Kickstarter to turn her vision into a reality. Uses of funds from the crowdfunding campaign will enable her to commence full-scale operations and hire team members.

Power Breakfast Blend contains only eight ingredients, including plant protein. The proprietary blend is delicious, easy and quick to prepare with the customer’s milk of choice.

For more information go to



Hugh Taylor
HB Publications, LLC
email us here

Source: EIN Presswire

OCI expands global footprint by announcing the launch of its new office in the Malaysian capital.

This expansion allows OCI to meet our client’s needs more efficiently within Asia, enabling seamless facilitation across our global trade and services.”

— Oliver Chapman, Group CEO of OCI Limited

LONDON, UNITED KINGDOM, March 5, 2021 / — The opening of this new office in Kuala Lumpur gives OCI a direct and local presence to better meet the Asian market’s high demand for sourcing, logistics and flexible financing. OCI Malaysia has collaborated with its partners across Southeast Asia, and is prepped for business worth over 5 billion USD in 2021.

Oliver Chapman, Group CEO of UK based OCI Limited said, “The decision to open the office in Asia was the next logical step in the growth strategy of our business. This expansion allows OCI to meet our client’s needs more efficiently within Asia, enabling seamless facilitation across our global trade and services.”

OCI has rapidly adapted to the ever-changing trade environment and the demands created by the COVID-19 pandemic. The new office will support the Malaysian government’s pandemic relief programs and those of other countries, including Indonesia and Sri Lanka.

Managing Director of OCI Malaysia, Ishtiaq M Khan said, “We are proud of our ability to successfully provide supplies and intelligent working capital solutions, supporting the demands of both public and private sectors.”

OCI’s flexible financing model provides the strength and capacity to handle a high volume of procurement. The organisation has a history of aiding governments and large corporations in Europe, the Middle East, USA and Asia. Providing liquidity to help them to optimise their capabilities in sourcing products and enhancing cash flow.

Executive Director of OCI Malaysia, Dato Azwanddin Hamzah said, “OCI Malaysia continues to develop the intelligent procurement strategies and flexible financial models offered to our partners – providing them with more choice and more innovative solutions within today's ever changing market.

OCI’s strategy is to continue supporting international organisations and governments in their procurement needs. The new Malaysian office will expand its global reach, including the Indonesian markets."

About OCI

OCI is a recognised global leader and innovator in the provision of end-to-end supply chain partnering services. Our strategy enables a stronger presence across several sectors including manufacturing, consumables, healthcare, agricultural and industrial sectors, and more specifically throughout the pandemic with PPE supplies.

Utilising our network of major global markets and decades of expertise in procurement, logistics and finance, OCI is able to link directly into the supply chains of its partners, enabling us to understand their requirements and alleviate any constraints.

Notes for Editors : Available for interviews and comments

OCI Malaysia
D5-5-1, Solaris Dutamas,
1 Jalan Dutamas 1, 50480
Kuala Lumpur
t: +603 6413 1533

33 Cannon Street
United Kingdom
Tel: +44 7963 090 378

Charlotte Victoria
OCI Limited
email us here
Visit us on social media:

Source: EIN Presswire